Assay of a seric human hexapeptide (HWESAS) using a monoclonal antibody and ELISA

Clinica Chimica Acta

Volumn 293, Issue 1-2, 2000, Pages 89-103

  Capiaumont, Josette ^a   Jacob, Christine ^a   Sarem, Mahrou ^a   Nabet, Pierre ^a   Belleville, Francine ^a   Dousset, Brigitte ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

ELISA; Kidney; Low molecular weight growth factor; Monoclonal antibody

Indexed keywords

HEXAPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; TECHNIQUE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; COMPLEMENT C3; ENZYME-LINKED IMMUNOSORBENT ASSAY; HAPTENS; HUMANS; HYBRIDOMAS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MICE; MICE, INBRED BALB C; OLIGOPEPTIDES; RENAL DIALYSIS;

EID: 0033981117     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00221-1     Document Type: Article

References (29)

1. Zapf J., Schmid C., Froesch E.R. Metabolic actions of insulin-like growth factors. Takano K., Hizuka N., Takahashi S.I. Molecular mechanisms to regulate the activities of insulin-like growth factors. 1998;341-349 Elsevier, Amsterdam.
2. Lewitt M.S. Role of the insulin-like growth factors in the endocrine control of glucose homeostasis. Diabete Res Clin Pract. 23:1994;3-15.
3. Jones J.J., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 16:1995;3-34.
4. Rechler M.M., Nissley S.P. Insulin-like growth factors: peptide growth factors and their receptors. Sporn M.B., Roberts A.B. Handbook of experimental pharmacology. 1st ed. 1990;263-267 Springer Verlag, New York.
5. Heulin M.H., Artur M., Malaprade D., Straczek J., Pierson M., Stoltz J.F., Belleville F., Paysant P., Nabet P. Evidence for the presence in human serum of an ultrafiltrable factor activating somatomedins. Biochem Biophys Res Commun. 99:1981;644-653.
6. Heulin M.H., Artur M., Geschier C., Straczek J., Vescovi G., Belleville F., Paysant P., Nabet P. The biological assay of human somatomedin A: improvement by small molecular mass natural molecules. Acta Endocrinol (Copenh). 106:1984;43-51.
7. Heulin M.H., Artur M., Straczek J., Belleville F., Nabet P., Herman A., Lebeurre M.D., Schimpff M. Effect of low molecular weight human serum factors and human somatomedin peptides in human lymphocytes culture. J Cell Sci. 57:1982;129-137.
8. Dousset B., Straczek J., Maachi F., Le Nguyen D., Jacob C., Capiaumont J., Nabet P., Belleville F. Purification from human plasma of a hexapeptide that potentiates the sulfatation and mitogenic activities of insulin-like growth factors. Biochem Biophys Res Commun. 247:1998;587-591.
9. Straczek J., Maachi F., Le Nguyen D., Becchi M., Heulin M.H., Nabet P., Belleville F. Purification from human plasma of a tetrapeptide that potentiates insulin-like growth factor-I activity in chick embryo cartilage. FEBS Lett. 373:1995;207-211.
10. Jacob C., Maachi F., El Farricha O., Dousset B., Kessler M., Belleville F., Nabet P. Role of the kidney in the expression of low molecular weight factors with growth factor activity. Clin Nephrol. 39:1993;327-334.
11. Jacob C., Hubert J., Maachi F., Punga-Maole A., Dousset B., Junke E., Belleville F. Role of the kidney in the production of a low molecular weight growth factor (MW<1000 Da): experimental study in the pig. Renal Failure. 17:1995;339-347.
12. Ganu V.S., Muller-Eberhard H.J., Hugli T.E. Factor C3f is a spasmogenic fragment released from C3b by factors I and H: the heptadecapeptide C3f was synthesized and characterized. Mol Immunol. 26:1989;939-948.
13. Le Nguyen D., Heitz A., Castro B. Renin substrates. Part 2 Rapid solid phase synthesis of the ratine sequence tetradecapeptide using BOP reagent. J Chem Soc, Perkin Trans. 1:1987;915-919.
14. Kearney J.F., Radbruch A., Liesegang B., Rajewski K. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction. J Immunol. 123:1979;1548-1557.
15. Littlefield J.W. Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants. Science. 145:1964;709.
16. Beatty J.D., Beatty G.B., Vlahos W.G. Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods. 100:1987;173-179.
17. Samokhin G.P., Filimonov I.N. Coupling of peptides to protein carriers by mixed anhydride procedure. Anal Biochem. 145:1985;311-314.
18. Rechlin M. Use of glutaraldehyde as a coupling for proteins and peptides. Methods Enzymol. 70:1980;159-165.
19. Bauminger S., Wilcheck M. The use of carbodiimides in the preparation of immunizing conjugates. Methods Enzymol. 70:1980;151-162.
20. Lin F.T., Zinnecker M., Hamaoka T., Katz D.T. New procedure for preparation and isolation of conjugates of proteins and a synthetic copolymer of diamino acids and immunological characterization of such conjugates. Biochemistry. 18:1979;690-717.
21. Modena D., Racchetti G., Putignano S., Comitti R., Galante Y.M. Production and characterization of murine monoclonal antibodies to polypeptide hormones and their fragments. Ann 1st Super Sanital. 27:1991;167-174.
22. Briand J.P., Muller S.M., Van Regenmortel M.H.W. Synthetic peptides as antigens: pitfalls of conjugation methods. J Immunol Methods. 78:1985;59-64.
23. Sondergard-Andersen J., Lauritzen E., Lind K., Holm A. Covalently linked peptides for enzyme-linked immunosorbent assay. J Immunol Methods. 131:1990;99-104.
24. Lambris J.D. The chemistry, biology, and phylogeny of C3. Cruse J.M., Lewis R.E. Jr. Complement today. Complement profiles. Vol. 1:1993;16-45 Karger, Basel.
25. Sanders P.W., Volanakis J.E., Stephen G., Rostand G., John H.G. Human complement protein D catabolism by the rat kidney. J Clin Invest. 77:1986;1299-1304.
26. Inagi R., Miyata T., Oda O., Maeda K., Inoue K. Evaluation of proteolytic activity of factor D accumulated as an active serine protease in patients with chronic renal failure. Nephron. 66:1994;285-290.
27. Volonakis J.E., Barnum S.R., Giddens M., Galla J.H. Renal filtration and catabolism of complement protein D. New Engl J Med. 312:1985;395-399.
28. Pascual M., Steiger G., Estreiger J., Macon K., Volonakis J.E., Jurg A., Schifferli J.A. Metabolism of complement factor D in renal failure. Kidney Int. 34:1988;529-536.
29. Tang S., Zhou W., Sherin N.S., Vaughan R., Sacks S.H. Contribution of renal secreted complement C3 to the circulating pool in human. J Immunol. 162:1999;4336-4341.